Efstathios Kastritis

Professor

National and Kapodistrian University of Athens

Greece

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Efstathios Kastritis is a faculty member at the National and Kapodistrian University of Athens, Greece. His research focuses on multiple myeloma, including therapeutic strategies and the impact of bone marrow microenvironment on patient outcomes. He has contributed significantly to the understanding of disease progression in hematologic conditions and has explored prognostic factors in oncology. His recent publications include systematic reviews, meta-analyses, and studies on the effectiveness of novel treatments.

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

GREECE

View details

Moshe E. Gatt

ISRAEL

View details

Giovanni Palladini

Full professor of Clinical Chemistry

Università degli Studi di Pavia

ITALY

View details

Michalis Liontos

National and Kapodistrian University of Athens

GREECE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Efstathios Kastritis

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

The Role of the Bone Marrow Microenvironment in Physical Function and Quality of Life in Patients with Multiple Myeloma After First-Line Treatment with Novel Agents and Autologous Transplantation

Yearly Assessment of Bone Disease in Patients with Asymptomatic Multiple Myeloma Identifies Early Progression Events and Should Be the Standard Clinical Practice

Upfront Anti-CD38 Monoclonal Antibody-Based Quadruplet Therapy for Multiple Myeloma: A Systematic Review and Meta-Analysis of Clinical Trials

Possible Prognostic Role of BMI Before Chemotherapy in the Outcomes of Women with Ovarian Cancer

Necrotizing Laryngitis in Patients with Hematologic Disease: The First Case-Report Due to PDR <i>Acinetobacter baumannii</i> and Literature Review

Integrated Network-Based Analysis of Diseases Associated with Amyloid Deposition Through a Disease–Protein–Drug Network

Trabecular Bone Score as a Complementary Tool for the Assessment of Bone Mineral Density in Patients with Asymptomatic Monoclonal Gammopathies

Real-World Effectiveness and Safety of Belantamab Mafodotin Monotherapy in Triple-Class Refractory Multiple Myeloma

<i>MYD88</i> Wild Type in IgM Monoclonal Gammopathies: From Molecular Mechanisms to Clinical Challenges

Use of Oral Antivirals Ritonavir-Nirmatrelvir and Molnupiravir in Patients with Multiple Myeloma Is Associated with Low Rates of Severe COVID-19: A Single-Center, Prospective Study

Venetoclax in Relapse/Refractory AL Amyloidosis—A Multicenter International Retrospective Real-World Study

Monoclonal Gammopathy of Thrombotic Significance

Tixagevimab/Cilgavimab as Pre-Exposure Prophylaxis against COVID-19 for Multiple Myeloma Patients: A Prospective Study in the Omicron Era

Approach to Contemporary Risk Assessment, Prevention and Management of Thrombotic Complications in Multiple Myeloma

Cardiopulmonary Exercise Physiology in AL Amyloidosis Patients with Cardiac Involvement and Its Association with Cardiac Imaging Parameters

Immune Checkpoint Inhibitors’ Associated Renal Toxicity: A Series of 12 Cases

Daratumumab Improves Bone Turnover in Relapsed/Refractory Multiple Myeloma; Phase 2 Study “REBUILD”

Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls

Collaborators (10)

Ioannis Ntanasis-Stathopoulos

Meletios Dimopoulos

Georgia Trakada

Despina Fotiou

Evangelos Terpos

Gerasimos Terzis

Kostas Stylianou

Moshe E. Gatt

Giovanni Palladini

Michalis Liontos

Make your next move.